Growth Metrics

Apyx Medical (APYX) Cash from Investing Activities Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Apyx Medical 174.53 Mn 143.65 Mn 7.93 Mn -9.09%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.09%
Dec 31, 2025 -12.24%
Sep 30, 2025 -239.22%
Jun 30, 2025 8.30%
Mar 31, 2025 -57.14%
Dec 31, 2024 -163.44%
Sep 30, 2024 12.07%
Jun 30, 2024 -104.06%
Mar 31, 2024 68.18%
Dec 31, 2023 34.51%
Sep 30, 2023 7.45%
Jun 30, 2023 1,873.32%
Mar 31, 2023 60.57%
Dec 31, 2022 57.23%
Sep 30, 2022 -10.59%
Jun 30, 2022 -1,282.76%
Mar 31, 2022 -45.31%
Dec 31, 2021 14.43%
Sep 30, 2021 -1,788.89%
Jun 30, 2021 69.15%
Mar 31, 2021 -113.33%
Dec 31, 2020 -72.44%
Sep 30, 2020 98.39%
Jun 30, 2020 -100.23%
Mar 31, 2020 -100.43%
Dec 31, 2019 96.35%
Sep 30, 2019 -101.56%
Jun 30, 2019 21,075.65%
Mar 31, 2019 15,093.53%
Dec 31, 2018 -3,090.67%
Sep 30, 2018 12,882.50%
Jun 30, 2018 -141.25%
Mar 31, 2018 -95.77%
Dec 31, 2017 -85.58%
Sep 30, 2017 -98.58%
Jun 30, 2017 -300.00%
Mar 31, 2017 -238.10%
Dec 31, 2016 67.19%
Sep 30, 2016 0.70%
Jun 30, 2016 90.38%
Mar 31, 2016 91.73%
Dec 31, 2015 -1.93%
Sep 30, 2015 8.39%
Jun 30, 2015 -133.71%
Mar 31, 2015 -238.67%
Dec 31, 2014 -81.87%
Mar 31, 2014 42.75%
Dec 31, 2013 43.75%
Mar 31, 2013 46.09%
Dec 31, 2012 -266.27%
Sep 30, 2012 18.18%
Jun 30, 2012 76.34%
Mar 31, 2012 -224.00%